Kookjeon Pharmaceutical Co., Ltd. (KOSDAQ:307750)

South Korea · Delayed Price · Currency is KRW

2,195.00

+50.00 (2.33%)

At close: Aug 20, 2026

Kookjeon Pharmaceutical Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	127,427	131,039	136,468	121,998	103,711	85,354
Revenue Growth	-5.92%	-3.98%	11.86%	17.63%	21.51%	-
Gross Profit	19,436	18,466	21,874	25,277	19,515	17,946
Operating Income	-14.25	-2,564	366.71	6,509	3,488	6,109
Net Income	-7,849	-4,299	1,736	4,824	8,948	4,038
Earnings Per Share	-156.21	-86.22	35.00	98.31	11.35	91.00
EPS Growth	-	-	-64.40%	766.11%	-87.53%	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	30,386	30,549	46,824	64,833	94,971	39,259
Total Debt	40,189	45,902	65,312	78,780	59,339	7,852
Net Cash (Debt)	-9,803	-15,354	-18,488	-13,947	35,632	31,407
Net Cash Growth	-	-	-	-	13.45%	-
Net Cash Per Share	-195.09	-307.93	-372.69	-284.24	695.44	712.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	8,446	10,608	9,967	-345.45	-6,019	3,042
Capital Expenditures	-3,919	-3,114	-7,867	-43,923	-23,285	-10,409
Free Cash Flow	4,527	7,494	2,100	-44,269	-29,304	-7,367
Free Cash Flow Growth	52.86%	256.91%	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	15.25%	14.09%	16.03%	20.72%	18.82%	21.02%
Operating Margin	-0.01%	-1.96%	0.27%	5.33%	3.36%	7.16%
Pretax Margin	-7.45%	-4.32%	0.64%	1.42%	10.69%	5.96%
Profit Margin	-6.16%	-3.28%	1.27%	3.95%	8.63%	4.73%
FCF Margin	3.55%	5.72%	1.54%	-36.29%	-28.26%	-8.63%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 20, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	99.34	63.47	36.30	133.06
P/FCF Ratio	11.09	22.53	82.14	-	-	-
PS Ratio	0.88	1.29	1.26	2.51	3.13	6.30